News
News

The latest updates from AFAR.

AFAR Experts in the News: Randall Bateman, Tammie Benzinger, Mathias Jucker, and Reisa Sperling on the relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease

Sep 28
2018

AFAR Experts in the News: Randall Bateman, Tammie Benzinger, Mathias Jucker, and Reisa Sperling on the relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease

On September 25, 2018, Alzheimer’s and Dementia: The Journal of the Ameican Alzheimer’s Association, published research co-authored by AFAR experts Randall Bateman, M.D., Tammie Benzinger, M.D., Ph.D., Mathias Jucker, Ph.D., and Reisa Sperling, M.D. Dr. Bateman is a 1997 Glenn/AFAR Scholarship for Research in the Biology of Aging, 2007 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, and 2015 recipient of the AFAR-administered MetLife Foundation Award for Medical Research in Alzheimer’s Disease recipient. Dr. Benzinger is a 1997 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient. Dr.…


View MoreREAD MORE


AFAR Experts in the News: Sebastian Brandhorst, Pinchas Cohen, Su Jeong Kim, Valter Longo, and Kelvin Yen in Nature on how humanin prevents age-related cognitive decline in mice

Sep 28
2018

AFAR Experts in the News: Sebastian Brandhorst, Pinchas Cohen, Su Jeong Kim, Valter Longo, and Kelvin Yen in Nature on how humanin prevents age-related cognitive decline in mice

On September 21, 2018, Nature published research co-authored by four AFAR experts: Sebastian Brandhorst, Ph.D., Pinchas Cohen, M.D., Su Jeong Kim, Ph.D., Valter Longo, Ph.D., and Kelvin Yen, Ph.D. Dr. Brandhorst is a 2017 Irene Diamond Fund/AFAR Postdoctoral Transition Awards in Aging recipient. Dr. Cohen is a 2017 Glenn Foundation for Medical Research Breakthroughs in Gerontology (BIG) Award winner. Dr. Kim is a 2014 Ellison/AFAR Postdoctoral Fellows in Aging Research Program recipient and a 2016 Glenn/AFAR Postdoctoral Fellowship Program for Translational Research on Aging recipient.   Dr. Longo is a 2013 Vincent Cristofalo Rising Star Award in…


View MoreREAD MORE


Awardee in the News: Valter Longo in Discover Magazine on the Fasting-Mimicking Diet

Sep 26
2018

Awardee in the News: Valter Longo in Discover Magazine on the Fasting-Mimicking Diet

On September 24, 2018, Discover Magazine highlighted the insights of AFAR expert Valter Longo, Ph.D. on the health benefits of fasting. Dr. Longo is a 2013 Vincent Cristofalo Rising Star Award in Aging Research recipient. Read “Not So Fast” here. Learn more about research on fasting and dietary timing in a free 1 hour webinar--"It’s Not Just What you Eat, but When”—on Thursday, September 27th 2018 from 2-3 PM EST (11-12pm PST) featuring a presentation by Dr. Longo as well as Dr. Satchin Panda. RSVP here. Read AFAR Scientific Director Steven Austad’s Next…


View MoreREAD MORE


Grantees in the News: Harlan M. Krumholz and Joseph S. Ross in The BMJ on research preprints and the potential healthcare benefits

Sep 26
2018

Grantees in the News: Harlan M. Krumholz and Joseph S. Ross in The BMJ on research preprints and the potential healthcare benefits

On September 24, 2018, The BMJ published an editorial co-authored by AFAR experts Harlan M. Krumholz, M.D., S.M. and Joseph S. Ross, M.D., M.H.S. on how “early publication of research finding without peer review could speed up knowledge dissemination.” Dr. Krumholz is a 1996 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar. Dr. Ross is a 2008 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar. Read “Will research preprints improve healthcare for patients?” here.


View MoreREAD MORE


Grantee in the News: Matt Kaeberlein in Medium on The Dog Aging Project and Rapamycin

Sep 24
2018

Grantee in the News: Matt Kaeberlein in Medium on The Dog Aging Project and Rapamycin

On September 19, 2018, Medium highlighted the research and insights of AFAR expert Matt Kaeberlein, Ph.D. on The Dog Aging Project and the potential of rapamycin to extend the lifespan and healthspan of dogs. Dr. Kaeberlein is a 2007 Glenn Foundation for Medical Research Breakthroughs in Gerontology (BIG) Award recipient. Read “Furrever Young” here. Learn more about The Dog Aging Project in this recorded webinar here.


View MoreREAD MORE


“Ask the Expert” Interview: Catherine Kaczorowski on Alzheimer’s disease, cognitive resilience, and the path to translation in humans

Sep 21
2018

“Ask the Expert” Interview: Catherine Kaczorowski on Alzheimer’s disease, cognitive resilience, and the path to translation in humans

AFAR is excited to announce the latest addition to our “Ask the Expert” series. In an exclusive interview, 2014 New Investigator Award in Alzheimer's Disease recipient and 2017 Glenn/AFAR Postdoctoral Fellowship Program for Translational Research on Aging Selection Committee member Catherine Kaczorowski, Ph.D., of The Jackson Laboratory, speaks about Alzheimer’s disease, resilience, and the path to translation in humans. Read Dr. Kaczorowski’s “Ask the Expert” interview on our InfoAging site here. This interview also appears on NextAvenue.org as part of an editorial partnership between AFAR and Next Avenue, public media…


View MoreREAD MORE


Board Member in the News: Next Avenue names Rudy Tanzi a 2018 Influencer in Aging

Sep 20
2018

Board Member in the News: Next Avenue names Rudy Tanzi a 2018 Influencer in Aging

In September, 2018, Next Avenue selected AFAR expert Rudolph E. Tanzi, Ph.D. as one of the 2018 Influencers in Aging. The Influencers in Aging award recognizes leaders in health, money, work, living, technology, and caregiving who are innovating the way we age and think about aging. Dr. Tanzi is an AFAR board member. Dr. Tanzi joins the ranks of several AFAR-affiliated experts who have received this recognition. In 2015, Next Avenue named 1993 AFAR Research Grant recipient and Director of the NIA’s Division of Aging Biology Felipe Sierra, Ph.D. an Influencer in Aging.  In 2016, AFAR board members Mark S.…


View MoreREAD MORE


Five AFAR experts contribute to special Geroscience feature of JAMA

Sep 18
2018

Five AFAR experts contribute to special Geroscience feature of JAMA

  Five AFAR experts contributed articles to a special feature in the prestigious Journal of the American Medical Association (JAMA), now available online. JAMA invited experts in aging research to discuss geroscience, the burgeoning research field that focuses on the genetic, molecular, and cellular mechanisms that make aging a major risk factor for most chronic diseases as we age. “The fact that JAMA, long one of the most highly influential and respected voices for the medical community, invited five AFAR experts to contribute articles on different aspects of geroscience vividly illustrates how this important and potentially transformative area of…


View MoreREAD MORE


Board Member in the News: Richard G. A. Faragher’s research in ScienceDaily on how disrupting genetic processes that regulate splicing reverses aging in human cells

Sep 17
2018

Board Member in the News: Richard G. A. Faragher’s research in ScienceDaily on how disrupting genetic processes that regulate splicing reverses aging in human cells

On September 13, 2018, ScienceDaily spotlighted recently published research by AFAR expert Richard G. A. Faragher, Ph.D. Dr. Faragher is an AFAR board member. Read “Disrupting genetic processes reverses aging in human cells” here and a related article in Health Medicine Network here.  Read the original published research in FASEB Journal here.   


View MoreREAD MORE


Board Member in the News: David Sinclair in The Atlantic and Crazy/Genius Podcast on the scientific forecast for human lifespan

Sep 14
2018

Board Member in the News: David Sinclair in The Atlantic and Crazy/Genius Podcast on the scientific forecast for human lifespan

On September 13, 2018, The Atlantic and Crazy/Genius podcast spotlighted the research and insights of AFAR expert David A. Sinclair, Ph.D. Dr. Sinclair is an AFAR board member and 2000 AFAR Research Grant recipient. Listen to the Crazy/Genius podcast here and read a related article--“Can Science Cure Aging?”-- here.


View MoreREAD MORE


Board member in the News: Rudy Tanzi in Science Magazine on how exercise generates new neurons and improves cognition in Alzheimer’s mice

Sep 13
2018

Board member in the News: Rudy Tanzi in Science Magazine on how exercise generates new neurons and improves cognition in Alzheimer’s mice

On September 7, 2018, Science Magazine published research co-authored by AFAR expert Rudolph E. Tanzi Ph.D. Dr. Tanzi is an AFAR board member. Read “Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer’s mouse model” here.


View MoreREAD MORE


AFAR Experts in the News: Rozalyn Anderson, Rafael de Cabo, and Yuji Ikeno in Cell Metabolism on fasting and longevity

Sep 11
2018

AFAR Experts in the News: Rozalyn Anderson, Rafael de Cabo, and Yuji Ikeno in Cell Metabolism on fasting and longevity

On September 6, 2018, Cell Metabolism published research co-authored by AFAR experts Rozalyn Anderson, Ph.D., Rafael de Cabo, Ph.D., and Yuji Ikeno, M.D., Ph.D. Dr. Anderson is a 2016 Glenn/AFAR Breakthroughs in Gerontology (BIG) Award winner. Dr. Cabo is a 2014 Vincent Cristofalo Rising Star Award in Aging Research winner. Dr. Ikeno is a 2008 Glenn Foundation for Medical Research Breakthroughs in Gerontology Award winner as well as a 2011-2017 National Scientific Advisory Council member. Read “Daily Fasting Improves Health and Survival in Male Mice Independent of Diet Composition and Calories” here. Learn more about the health benefits…


View MoreREAD MORE


Grantee in the News: Timothy Jarome in The Journal of Neuroscience on how EZH2 Methyltransferase Activity Controls Pten Expression and mTOR Signaling during Fear Memory Reconsolidation

Sep 11
2018

Grantee in the News: Timothy Jarome in The Journal of Neuroscience on how EZH2 Methyltransferase Activity Controls Pten Expression and mTOR Signaling during Fear Memory Reconsolidation

On August 29, 2018, The Journal of Neuroscience published research co-authored by AFAR expert Timothy Jarome, Ph.D. Dr. Jarome is a 2016 Glenn/AFAR Postdoctoral Fellowship Program for Translational Research on Aging recipient. Read “EZH2 Methyltransferase Activity Controls Pten Expression and mTOR Signaling during Fear Memory Reconsolidation” here.


View MoreREAD MORE


Board Member in the News: Nir Barzilai in Medium on the Targeting Aging with Metformin (TAME) Trial

Sep 10
2018

Board Member in the News: Nir Barzilai in Medium on the Targeting Aging with Metformin (TAME) Trial

On September 5, 2018, Medium shared the insights of AFAR expert Nir Barzilai,  M.D. and highlighted the AFAR-managed Targeting Aging with Metformin (TAME) Trial. Dr. Barzilai is AFAR’s Deputy Scientific Director as well as a 1997 Beeson Scholar and 1994 AFAR Research Grant recipient. Read  “The Safe, Boring, and Extremely Cheap Drug That Could Cure Aging” here.


View MoreREAD MORE


Grantee in the News: Pankaj Kapahi’s Research in Cell Metabolism on the role of advanced glycation end products in aging and metabolic diseases

Sep 10
2018

Grantee in the News: Pankaj Kapahi’s Research in Cell Metabolism on the role of advanced glycation end products in aging and metabolic diseases

On September 4, 2018, Cell Metabolism published research co-authored by AFAR expert Pankaj Kapahi, Ph.D. Dr. Kapahi has received multiple AFAR grants including: a 2001 Glenn/AFAR Postdoctoral Fellowship, a 2006 Glenn/AFAR Breakthroughs in Gerontology (BIG) Award, and a 2011 Julie Martin Mid-Career Award in Aging Research. He also served on AFAR’s National Scientific Advisory Council in 2011, 2013, 2014, and 2015. Read, “The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality,” here.


View MoreREAD MORE


AFAR Experts in the News: Sofiya Milman and S. Jay Olshansky in WebMD magazine on genes, longevity, and the TAME Trial

Sep 07
2018

AFAR Experts in the News: Sofiya Milman and S. Jay Olshansky in WebMD magazine on genes, longevity, and the TAME Trial

In its September 2018 issue, WedMD magazine highlighted the insights of AFAR experts Sofiya Milman M.D. and S. Jay Olshansky Ph.D. Dr. Milman is a 2015 Beeson Career Development Awards in Aging Research scholar. Dr. Olshansky is an AFAR Board Member and 2016 Irving S. Wright Award winner. The article also explores the Targeting Aging with Metformin (TAME) Trial,  which is led by AFAR Deputy Scientific Director Nir Barzilai, M.D. and managed by AFAR. Read the article--“100: Is It The New 80?”—here.


View MoreREAD MORE


Awardee in the News: Valter Longo in Forbes on the science behind the health benefits of fasting and the fasting-mimicking diet

Sep 05
2018

Awardee in the News: Valter Longo in Forbes on the science behind the health benefits of fasting and the fasting-mimicking diet

On September 4, 2018, Forbes highlighted the research of AFAR expert Valter D. Longo, Ph.D. exploring the health benefits of a fast-mimicking diet and fasting. Dr. Longo is a 2013 Vincent Cristofalo Rising Star Award in Aging Research recipient. Read the article--“Can Fasting Help You Lose Weight? (Or Maybe Live Longer?)”--here. Hear more of Dr. Longo’s insights on fasting in a free webinar on Thursday, September 27th from 2-3pm Eastern time. Learn more and RSVP here.


View MoreREAD MORE


Grantee in the News: Satchidananda Panda on time-restricted feeding, obesity, and metabolic syndrome

Sep 04
2018

Grantee in the News: Satchidananda Panda on time-restricted feeding, obesity, and metabolic syndrome

On August 30, 2018, Cell Metabolism published research co-authored by AFAR expert Satchin Panda, Ph.D. Dr. Panda is a 2014 Julie Martin Mid-Career Award in Aging Research recipient. Read the full article, “Time-Restricted Feeding Prevents Obesity and Metabolic Syndrome in Mice Lacking a Circadian Clock,” here. Hear more of Dr. Panda’s insights on time-restricted feeding in a free webinar on Thursday September 27 from 2-3pm EST. Learn more and RSVP here.


View MoreREAD MORE


AFAR experts in the News: Harvey Jay Cohen, Arti Hurria, and Heidi Klepin in The Journal of the American Geriatrics Society on chemotherapy and breast cancer patients’ functional decline, and resilience.

Sep 04
2018

AFAR experts in the News: Harvey Jay Cohen, Arti Hurria, and Heidi Klepin in The Journal of the American Geriatrics Society on chemotherapy and breast cancer patients’ functional decline, and resilience.

On August 26, 2018, the Journal of the American Geriatrics Society published research co-authored by AFAR experts Harvey Jay Cohen M.D., Arti Hurria M.D., and Heidi Klepin M.D. Dr. Cohen is an AFAR board member and former Board President. Dr. Hurria is a 2005 Paul B. Beeson Career Development Award in Aging Research scholar. Dr. Klepin is a 2011 Paul B. Beeson Career Development Award in Aging Research scholar and a 2011 John A. Hartford Center of Excellence scholar. Read, “Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer,” here.


View MoreREAD MORE




BACK TO TOPBACK TO TOP